Related Experiment Video
Updated: Apr 16, 2026

04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
2.7K
Polyclonal selection of immune checkpoint mutations in thyroid autoimmunity.
Pantelis A Nicola1, Andrew R J Lawson2, Alexandra Tidd1
1Somatic Genomics Programme, Wellcome Sanger Institute, Hinxton, UK.
Nature
|April 14, 2026
Summary
Somatic mutations in immune checkpoint genes like TNFRSF14 and CD274 allow self-reactive lymphocytes to escape immune tolerance, driving autoimmune thyroid disease through a polyclonal cascade of somatic evolution.
Area of Science:
- Immunology
- Genetics
- Molecular Biology
Background:
- The immune system has checkpoints to prevent self-reactive lymphocytes.
- Understanding how lymphocytes escape these checkpoints to cause autoimmune disease is crucial.
Purpose of the Study:
- To investigate the role of somatic mutations in immune-regulatory genes in autoimmune thyroid disease.
- To identify specific genetic mutations enabling self-reactive lymphocytes to bypass tolerance.
Main Methods:
- Whole-exome and targeted NanoSeq for mutation detection.
- Laser microdissection, methylation sequencing, spatial transcriptomics, and single-nucleus DNA sequencing.
- Immunostaining and antibody synthesis to characterize mutant clones.
Main Results:
- Identified convergent loss-of-function mutations in TNFRSF14 (HVEM) and CD274 (PD-L1) in B cells.
- Detected numerous independent immune checkpoint mutant clones in inflamed thyroid biopsies.
- Confirmed self-reactivity and multiple mutations within individual B cell clones, including widespread biallelic loss of TNFRSF14.
Conclusions:
- Somatic mutations in immune checkpoint genes contribute to autoimmune disease pathogenesis.
- A polyclonal cascade of somatic evolution allows self-reactive lymphocytes to escape tolerance.
- These findings offer new molecular insights into the basis of autoimmune diseases.
Related Concept Videos
Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Synthesis and Regulation of Thyroid Hormones
9.4K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
9.4K
T Cell Activation and Clonal Selection
17.9K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
17.9K

